Retrospective review using targeted deep sequencing reveals mutational differences between gastroesophageal junction and gastric carcinomas
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Retrospective review using targeted deep sequencing reveals mutational differences between gastroesophageal junction and gastric carcinomas
Authors
Keywords
Gastric cancer, Gastroesophageal junction cancer, Gastric cancer genomics, Gastric cancer sequencing
Journal
BMC CANCER
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-02-05
DOI
10.1186/s12885-015-1021-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML
- (2013) A. Chaturvedi et al. BLOOD
- Inhibitor-Sensitive FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma
- (2013) R. G. Liao et al. CANCER RESEARCH
- High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers
- (2013) Matteo Fassan et al. Gastric Cancer
- Ponatinib (AP24534) Is a Novel Potent Inhibitor of Oncogenic RET Mutants Associated With Thyroid Cancer
- (2013) Valentina De Falco et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Targeted Next-Generation Sequencing Panel (ThyroSeq) for Detection of Mutations in Thyroid Cancer
- (2013) Marina N. Nikiforova et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinical Validation of a Next-Generation Sequencing Screen for Mutational Hotspots in 46 Cancer-Related Genes
- (2013) Rajesh R. Singh et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Molecular Diagnostic Profiling of Lung Cancer Specimens with a Semiconductor-Based Massive Parallel Sequencing Approach
- (2013) Volker Endris et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Targeted, High-Depth, Next-Generation Sequencing of Cancer Genes in Formalin-Fixed, Paraffin-Embedded and Fine-Needle Aspiration Tumor Specimens
- (2013) Andrew G. Hadd et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Next-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine clinical diagnostics
- (2013) Rashmi Kanagal-Shamanna et al. MODERN PATHOLOGY
- Targeting Protein Tyrosine Phosphatase SHP2 for the Treatment of PTPN11-Associated Malignancies
- (2013) B. Yu et al. MOLECULAR CANCER THERAPEUTICS
- Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity
- (2013) Austin M Dulak et al. NATURE GENETICS
- Gastric cancer—molecular and clinical dimensions
- (2013) Roopma Wadhwa et al. Nature Reviews Clinical Oncology
- Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer
- (2013) Manish A. Shah et al. PLoS One
- Comparison of Global Gene Expression of Gastric Cardia and Noncardia Cancers from a High-Risk Population in China
- (2013) Gangshi Wang et al. PLoS One
- Molecular Typing of Lung Adenocarcinoma on Cytological Samples Using a Multigene Next Generation Sequencing Panel
- (2013) Aldo Scarpa et al. PLoS One
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Helicobacter pyloriinfection and esophageal cancer risk: An updated meta-analysis
- (2013) Fa-Jun Xie WORLD JOURNAL OF GASTROENTEROLOGY
- Activating Mutations in ERBB2 and Their Impact on Diagnostics and Treatment
- (2013) Grit S. Herter-Sprie et al. Frontiers in Oncology
- A meta-analysis of body mass index and esophageal and gastric cardia adenocarcinoma
- (2012) F. Turati et al. ANNALS OF ONCOLOGY
- PIK3CA Mutation H1047R Is Associated with Response to PI3K/AKT/mTOR Signaling Pathway Inhibitors in Early-Phase Clinical Trials
- (2012) F. Janku et al. CANCER RESEARCH
- A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer
- (2012) J. Berlin et al. CLINICAL CANCER RESEARCH
- Combining Highly Multiplexed PCR with Semiconductor-Based Sequencing for Rapid Cancer Genotyping
- (2012) Carol Beadling et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study
- (2012) Pasi A Jänne et al. LANCET ONCOLOGY
- Ponatinib (AP24534), a Multitargeted Pan-FGFR Inhibitor with Activity in Multiple FGFR-Amplified or Mutated Cancer Models
- (2012) J. M. Gozgit et al. MOLECULAR CANCER THERAPEUTICS
- Vemurafenib: the first drug approved for BRAF-mutant cancer
- (2012) Gideon Bollag et al. NATURE REVIEWS DRUG DISCOVERY
- Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors
- (2012) M. McTigue et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epidemiology and Risk Factors for Gastroesophageal Junction Tumors: Understanding the Rising Incidence of This Disease
- (2012) Matthew F. Buas et al. SEMINARS IN RADIATION ONCOLOGY
- Janus Kinase 3–Activating Mutations Identified in Natural Killer/T-cell Lymphoma
- (2012) Ghee Chong Koo et al. Cancer Discovery
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Molecular Classification of Gastric Cancer: A New Paradigm
- (2011) M. A. Shah et al. CLINICAL CANCER RESEARCH
- Deep sequencing of gastric carcinoma reveals somatic mutations relevant to personalized medicine
- (2011) Joanna D Holbrook et al. Journal of Translational Medicine
- Potent Activity of Ponatinib (AP24534) in Models of FLT3-Driven Acute Myeloid Leukemia and Other Hematologic Malignancies
- (2011) J. M. Gozgit et al. MOLECULAR CANCER THERAPEUTICS
- Aetiology and classification of adenocarcinoma of the gastro-oesophageal junction/cardia
- (2010) K. E. L. McColl et al. GUT
- Differences of immunophenotypic markers and signaling molecules between adenocarcinomas of gastric cardia and distal stomach
- (2010) Liying Xue et al. HUMAN PATHOLOGY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Gastric cardiac carcinomas involving the esophagus are more adequately staged as gastric cancers by the 7th edition of the American Joint Commission on Cancer Staging System
- (2010) Qin Huang et al. MODERN PATHOLOGY
- Serum pepsinogens and risk of gastric and oesophageal cancers in the General Population Nutrition Intervention Trial cohort
- (2009) J-S Ren et al. GUT
- KRAS Mutation
- (2009) Wilbur A. Franklin et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
- (2009) Lenny Dang et al. NATURE
- Helicobacter pylori and Esophageal Cancer Risk: A Meta-analysis
- (2008) F. Islami et al. Cancer Prevention Research
- Somatic Mutations of JAK1 and JAK3 in Acute Leukemias and Solid Cancers
- (2008) E. G. Jeong et al. CLINICAL CANCER RESEARCH
- Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer
- (2007) M H Derakhshan et al. GUT
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now